ClinConnect ClinConnect Logo
Search / Trial NCT01152333

The Role of GLP-1 in Satiety Perception in Humans

Launched by UNIVERSITY OF WASHINGTON · Jun 25, 2010

Trial Information

Current as of July 02, 2025

Withdrawn

Keywords

ClinConnect Summary

Many times each day, we see food or representations of food and evaluate whether or not the food looks good to us. If it does, we then balance external factors, such as the social situation or time of day, against internal signals about our hunger state in order to decide what and when to eat. However, recent functional magnetic resonance imaging (fMRI) studies suggest that internal signals, such as hormones regulating appetite and satiety, govern our food intake in part by acting on neural circuits to affect whether a given food appears appetizing at that moment. In addition, photographs o...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male or female between 18-29 years of age
  • 2. BMI between 18.5-24.9 kg/m2
  • 3. Written informed consent obtained from subject and ability for subject to comply with the requirements of the study.
  • Exclusion Criteria:
  • 1. Chronic health conditions, including diabetes and kidney disease.
  • 2. Current dieting for weight loss or restrained eating
  • 3. History of obesity, eating disorders, or weight loss surgery
  • 4. Random blood glucose \>140
  • 5. Pregnancy or use of oral contraceptives
  • 6. Current smoker
  • 7. Recreational drug use or alcohol use of \> 1 drink per day for females, \> 2 per day for males
  • 8. Food allergy or intolerance to study foods.
  • 9. Medications known to alter appetite (e.g., amphetamines, atypical antipsychotics) or gastric emptying (e.g., metoclopromide)
  • 10. Contraindications to MRI, such as implanted metal or claustrophobia.
  • 11. Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Ellen A Schur, M.D., M.S.

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials